Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: O-Propargylpuromycin, OP-puro


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 500 μg | $46 | In Stock | In Stock | |
| 1 mg | $66 | In Stock | In Stock | |
| 5 mg | $158 | In Stock | In Stock | |
| 10 mg | $248 | In Stock | In Stock | |
| 25 mg | $397 | In Stock | In Stock | |
| 50 mg | $569 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $175 | In Stock | In Stock |
| Description | O-Propargyl-Puromycin ( OP-puro) is a natural product derivative and a protein synthesis inhibitor with cell permeability. It terminates translational elongation by incorporation into nascent peptide chains, and is widely used for nascent protein labeling and detection, enabling fluorescence imaging or affinity enrichment when combined with click chemistry. |
| In vitro | Methods: Reticulocyte lysates and 293T cells were treated with O-Propargyl-Puromycin (25 μM) for 1 hour, and protein synthesis inhibition was detected by SDS-PAGE and autoradiography. Nascent polypeptide labeling was assessed through copper-catalyzed click chemistry combined with affinity purification. Results: O-Propargyl-Puromycin inhibited protein synthesis with an efficacy of 1/2 to 1/3 that of puromycin, covalently bound to nascent peptide chains, and was rapidly degraded by the proteasome, making it applicable for imaging of nascent proteins in cells and tissues. [1] |
| In vivo | Methods: Intraperitoneal injection of O-Propargyl-Puromycin (20 mM, 100 μL, dissolved in PBS) was administered to 3-week-old mice. Tissues were harvested and fixed 1 hour post-injection, followed by CuAAC staining with TMR-azide. PBS-injected mice served as controls. Results: Strong staining was observed in the small intestinal crypts and Paneth cells of injected mice, with distinct labeling of secretory granules, confirming that O-Propargyl-Puromycin can specifically label nascent proteins in vivo. [1] |
| Synonyms | O-Propargylpuromycin, OP-puro |
| Molecular Weight | 495.53 |
| Formula | C24H29N7O5 |
| Cas No. | 1416561-90-4 |
| Smiles | CN(C)c1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](NC(=O)[C@@H](N)Cc2ccc(OCC#C)cc2)[C@H]1O |
| Relative Density. | 1.44 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 257.5 mg/mL (519.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (10.09 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.